INTRODUCING OUR NEW CLIENT

Khiron Life Sciences Corp.

 (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt:A2JMZC)

Khiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health centres and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico in 2021. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors. Visit Khiron online at investors.khiron.ca and on Instagram @khironlife.

For more information or to arrange a meeting with Khiron, please contact Lytham Partners at 602-889-9700 or email 1×1@lythampartners.com.